Carmell Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Public Listing
PITTSBURGH–(BUSINESS WIRE)–Carmell Therapeutics, a pioneering company in the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs) to accelerate bone and soft tissue healing, today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed public listing of its Class … [Read more…]
